Skip to main content
KimeraCHEMS
Display
  • C
  • N
  • O

Calculated reference model · not an experimental or batch-certified structure. All 18 atoms shown.

Model data & sources
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
  • Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
Formula
C14H18N2O2
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer
Reports
2 on file
Everything shipping from this page today came off this batch. The code is printed on your label, and one certificate covers the whole batch.

Sunifiram

Nootropics

Published formats

  • Powder 1g
  • Liquid Dropper 30ml/20mg Per ml/600mg
  • Tablets 30ct/20mg/600mg
What is the difference between these?
Powder
Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Liquid Dropper
The compound already in solution, in a dropper bottle. The label gives the amount per millilitre, the bottle volume and the total.
Tablets
Pressed tablets. The label gives the amount in each tablet and the number in the bottle.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Technical Specifications

Batch COA Database ↗
CAS Registry Number314728-85-3
Molecular FormulaC₁₄H₁₈N₂O₂
Molecular Weight246.31
IUPAC Designation1-(4-benzoylpiperazin-1-yl)propan-1-one
Physical FormFine white or off-white powder
Storage RequirementsRefer to product documentation
Solution VehiclePhosphate Buffered Solution, EDTA
Other Names314728-85-3, DM 235, DM-235, 1-(4-benzoylpiperazin-1-yl)propan-1-one, 66924E735K, DM235 cpd, Lopac-D-5689
Liquid Concentration and Solution20mg Per mL, Phosphate Buffered Solution, EDTA
Bulk Powder Quantity1g
Tablet Concentration20mg x 30ct

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

Sunifiram (DM-235) Research Standard

Sunifiram (DM-235) is a highly potent synthetic compound belonging to the racetam class of chemicals. Distinguishable by its significantly increased potency compared to earlier molecules such as piracetam, Sunifiram is utilized in laboratory research as a powerful tool for investigating excitatory amino acid receptor signaling. In in vitro models, it serves as a reference material for probing the modulation of AMPA and NMDA receptors and observing the resulting changes in nerve cell activity, synaptic signaling, and cognitive-related neuroplasticity pathways.

Physical & Handling Properties

Property Specification
Physical Appearance Fine white or off-white powder
Solution Base Phosphate Buffered Solution, EDTA

Mechanism of Action & Research Context

Sunifiram is primarily investigated for its pharmacological impact on glutamatergic signaling systems in neural tissue.

  • Receptor Modulation: The compound is characterized by its activity at both AMPA and NMDA receptors. It is hypothesized to function as a positive allosteric modulator, which enhances the signaling efficiency of these receptors in isolated cell preparations.

  • Potency Profile: Sunifiram shows high binding affinity and potency relative to first-generation racetams, which matters when setting concentration ranges in receptor activation assays.

  • Signaling Pathways: Research utilizing Sunifiram focuses on its ability to potentiate synaptic transmission, making it a critical reagent for studying the mechanisms of long-term potentiation (LTP) and synaptic plasticity.

Research Applications

Sunifiram is a specialized reagent used to explore the dynamics of glutamatergic signaling and cognitive neurobiology.

Primary fields of in vitro laboratory investigation include:

  • Memory & Plasticity Studies: Examining changes in hippocampal tissue model activity to understand the mechanisms of neuroplasticity.

  • Synaptic Activity: Monitoring real-time signal propagation and movement between nerve cells in culture.

  • Focus & Pathway Research: Observing pathway activity in attention-related research models.

  • Receptor Signaling: Characterizing the dose-response relationship of AMPA/NMDA receptor activity in controlled nerve tissue environments.

  • Comparative Racetam Analysis: Utilizing Sunifiram as a high-potency benchmark when comparing the efficacy of structurally diverse racetam-class compounds.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed. Liquid formats: do not refrigerate or freeze. Cold storage may cause the solution to cloud or precipitate. If this occurs, return to room temperature and mix until clear.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Currently shipping from batch KC-SUF-01.

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.